3 Explosive Stocks With High Short Interest
Briefly

3 Explosive Stocks With High Short Interest
"Viking Therapeutics (NASDAQ: VKTX): With 23% of its float short, Viking Therapeutics has been gaining momentum. In fact, since bottoming out at around $25, it's now up to $35.22 and climbing. Fueling upside, analysts at Canaccord initiated coverage of the obesity treatment stock with a buy rating and a price target of $106 a share. The company is also seeing progress in its Phase 3 VANQUISH trial for the injectable obesity drug VK2735."
"NuScale Power (NYSE: SMR): With a short interest of 22.6%, NuScale has also been explosive. Since bottoming out at $32.50, SMR is now back to $43.17 and rallying. For one, there's growing demand for nuclear energy, especially with explosive demand from data centers. Two, analysts at Cantor Fitzgerald just initiated coverage of SMR with an overweight rating and a price target of $55 a share."
"Lemonade (NYSE: LMND): With a short interest of 25%, Lemonade has been just as explosive. Since bottoming out at around $47.50, LMND is now at $60.71 and could also push aggressively higher. Analysts believe Lemonade's earnings on November 5 could send the stock soaring, especially with its exposure to artificial intelligence. By using AI for just about every part of its business, it's been delivering faster, more efficient, and transparent insurance information."
High short interest can indicate elevated risk and potential for short squeezes when stocks rally. Viking Therapeutics (VKTX) has 23% of its float short and has risen from about $25 to $35.22; Canaccord initiated coverage with a buy rating and $106 price target. Viking reports progress in Phase 3 VANQUISH trials for VK2735 with VANQUISH-1 enrollment expected complete by end-2025 and VANQUISH-2 by 1Q26. NuScale Power (SMR) has 22.6% short interest and moved from $32.50 to $43.17 amid nuclear demand and Cantor Fitzgerald coverage with a $55 target. Lemonade (LMND) has 25% short interest, rose from about $47.50 to $60.71, uses AI across operations, and had 2.7 million policyholders (24% YoY growth).
Read at 24/7 Wall St.
Unable to calculate read time
[
|
]